Fifth Third Bancorp Novo Cure LTD Transaction History

Fifth Third Bancorp

$27.1 Billion
Q4 2024

A detailed history of Fifth Third Bancorp transactions in Novo Cure LTD stock. As of the latest transaction made, Fifth Third Bancorp holds 2,500 shares of NVCR stock, worth $44,550. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,500

Previous 2,500 -0.0%

Holding current value

$44,550

Previous $39,000 89.74%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$11.83 - $24.05 $29,575 - $60,125	2,500 New	2,500 $42,000
Q4 2023 Jan 19, 2024	SELL	$11.13 - $15.78 $2,827 - $4,008	-254 Reduced 20.26%	1,000 $14,000
Q3 2023 Oct 31, 2023	SELL	$16.15 - $42.35 $12,112 - $31,762	-750 Reduced 37.43%	1,254 $20,000
Q2 2023 Jul 25, 2023	BUY	$40.29 - $82.51 $40,290 - $82,510	1,000 Added 99.6%	2,004 $83,000
Q1 2023 Apr 24, 2023	SELL	$56.44 - $118.81 $125,917 - $265,065	-2,231 Reduced 68.96%	1,004 $60,000
Q4 2022 Jan 25, 2023	BUY	$63.98 - $85.37 $57,326 - $76,491	896 Added 38.31%	3,235 $0
Q3 2022 Oct 25, 2022	BUY	$67.99 - $89.57 $87,911 - $115,814	1,293 Added 123.61%	2,339 $178,000
Q1 2022 Apr 19, 2022	BUY	$60.15 - $84.52 $481 - $676	8 Added 0.77%	1,046 $87,000
Q4 2021 Feb 01, 2022	BUY	$75.08 - $121.99 $2,853 - $4,635	38 Added 3.8%	1,038 $78,000
Q3 2021 Oct 15, 2021	SELL	$116.17 - $194.55 $1,858 - $3,112	-16 Reduced 1.57%	1,000 $116,000
Q2 2021 Aug 06, 2021	BUY	$130.4 - $225.58 $2,086 - $3,609	16 Added 1.6%	1,016 $225,000
Q1 2021 May 07, 2021	SELL	$124.11 - $190.17 $362,525 - $555,486	-2,921 Reduced 74.5%	1,000 $132,000
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $142,443 - $221,157	1,270 Added 47.91%	3,921 $678,000
Q3 2020 Nov 09, 2020	BUY	$58.05 - $111.31 $15,673 - $30,053	270 Added 11.34%	2,651 $295,000
Q2 2020 Aug 05, 2020	BUY	$57.2 - $74.41 $69,669 - $90,631	1,218 Added 104.73%	2,381 $141,000
Q1 2020 May 05, 2020	BUY	$57.05 - $95.75 $9,013 - $15,128	158 Added 15.72%	1,163 $78,000
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $9,971 - $13,694	146 Added 17.0%	1,005 $85,000
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $56,478 - $89,291	-913 Reduced 51.52%	859 $64,000
Q2 2019 Aug 07, 2019	BUY	$42.22 - $63.23 $13,425 - $20,107	318 Added 21.87%	1,772 $112,000
Q1 2019 May 14, 2019	BUY	$31.96 - $56.12 $18,472 - $32,437	578 Added 65.98%	1,454 $70,000
Q4 2018 Feb 14, 2019	BUY	$28.72 - $52.63 $373 - $684	13 Added 1.51%	876 $29,000
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $2,048 - $3,353	64 Added 8.01%	863 $45,000
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $15,860 - $25,568	799 New	799 $25,000

Others Institutions Holding NVCR

# of Institutions

291

Shares Held

75.7M

Call Options Held

1.77M

Put Options Held

538K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.87B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Novo Cure LTD Transaction History